Fermented oat-based product

1 paper3 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Funders: European Commission and 2 more
3 of 3 findings with company ties

Human trial1

Outcomes

Ferritin

downin humans1

1 study

Fermented oat-based product decreases ferritin in humans (-4.00 [-16.50, 6.25] μg/L).
Human trialhabitual dietfermented oat-based product (gurt)three weeksn = 56
Role of bioprocessing in modifying cardiometabolic outcomes of an oat-based dairy alternative in a randomised controlled clinical intervention
Clinical nutrition (Edinburgh, Scotland)29 Jul 2026

Latest

1 in 12 months

Clinical Nutrition10 Aug

Role of bioprocessing in modifying cardiometabolic outcomes of an oat-based dairy alternative in a randomised controlled clinical intervention

Randomised trial in 56 peopleInterventions

Paper

Fermented oat-based product

Outcomes

Latest

Role of bioprocessing in modifying cardiometabolic outcomes of an oat-based dairy alternative in a randomised controlled clinical intervention

Related